**Exhibit 31.1**

 

Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002 and pursuant to Rule13a-14(a) and Rule 15d-14 under the Securities Exchange Act of 1934 

 

Inconnection with the Quarterly Report Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 on Form 10-QSB of Bio Tracking Security Inc. (the “Company”) for the period ended September 30, 2004, as filed with the Securitiesand Exchange Commission on the date hereof (the “Report”), I, Jean-Francois Amyot, CEO of the Company, certify, pursuant to 18 U.S.C. Sec. 1350, as adopted pursuant to Section 302 and 906 of the Sarbanes-Oxley Act of 2002, and pursuant toRule 13a-14 under the Securities Exchange Act of 1934, that: 

 

1. I havereviewed the Report being filed; 

 

2. Based on my knowledge, the Report does notcontain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by theReport; 

 

3. Based on my knowledge, the financial statements, and otherfinancial information included in the Report, fairly present in all material respects the financial condition, results of operations and cash flows of the Company as of, and for, the period presented in the Report; 

 

4. I and the other certifying officers are responsible for establishing and maintainingdisclosure controls and procedures (as such term is defined in paragraph (c) of Rule 13a-14) for the Company and have: 

 

i. Designed such disclosure controls and procedures to ensure that material information relating to the Company, including its consolidated subsidiaries,if any, is made known to them by others within those entities, particularly during the period in which the periodic reports are being prepared; 

 

ii. Evaluated the effectiveness of the Company’s disclosure controls and procedures as of a date within 90 days prior to the filing date of theReport (“Evaluation Date”); and 

 

iii. Presented inthe Report their conclusions about the effectiveness of the disclosure controls and procedures based on their evaluation as of the Evaluation Date; 

 

5. I and the other certifying officers have disclosed, based on their most recent evaluation, to the Company’s auditors and the audit committee of the board ofdirectors (or persons fulfilling the equivalent function): 

 

i.All significant deficiencies in the design or operation of internal controls which could adversely affect the Company’s ability to record, process, summarize and report financial data and have identified for the Company’s auditors anymaterial weaknesses in internal controls; and 

 

ii. Any fraud,whether or not material, that involves management or other employees who have a significant role in the Company’s internal controls; and 

 

6. I and the other certifying officers have indicated in the report whether or not there were significant changes in internal controls or in other factors that couldsignificantly affect internal controls subsequent to the date of their most recent evaluation, including any corrective actions with regard to significant deficiencies and material weaknesses. 

 

Dated: November 22, 2004